Clinical Trial Update: Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 dose-escalation trial assessed BG9924 in combination with methotrexate in active rheumatoid arthritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BG9924
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Biogen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED